Jump to content

Thai Senate passes bill on use of anti-libidinal drugs on repeat sex offenders


snoop1130

Recommended Posts

ฉีดไข่ฝ่อ-1024x683.jpg

Photo from Freepik

 

The Thai Senate approved yesterday (Monday) a bill to deal with repeat sex offenders, legalising the use of anti-libidinal drugs to suppress or reduce sex drive. The bill passed by 137-3 votes with four abstentions, according to Deputy Senate Speaker Supachai Somcharoen.

 

After the approval by the Senate, the bill will now go to the cabinet for consideration.

 

Under the bill, medication can be prescribed only with the approval of a psychiatric specialist and an internal medicine specialist, and with the consent of the sex offender in question. This measure can also be applied to offenders after they have served their sentences, or those who are in rehabilitation, to prevent repetition of the offence.

 

Full Story: https://www.thaipbsworld.com/thai-senate-passes-bill-on-use-of-anti-libidinal-drugs-on-repeat-sex-offenders/

 

Logo-top-.png

-- © Copyright Thai PBS 2022-07-12
 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

Monthly car subscription with first-class insurance, 24x7 assistance and more in one price - click here to find out more!

  • Like 1
  • Confused 3
Link to comment
Share on other sites

17 hours ago, snoop1130 said:

Under the bill, medication can be prescribed only with the approval of a psychiatric specialist and an internal medicine specialist, and with the consent of the sex offender in question.

????

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...